← Leaderboards
Phillip Ishikawa
Advanced Bioscience Laboratories, Inc.
$23,550,479
Attributed
$23,550,479
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $13.7M · FY2015–23$20M$15M$10M$5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$23,550,479 · 3
By mechanism
N01$23,550,479 · 3
Top collaborators
No co-investigators on record.
Most similar at Advanced Bioscience Laboratories, Inc.
Same institution · by research overlap
- Ranajit Pal$45,474,422
- Timothy Fouts$52,990,932
- Thomas Vancott$47,641,448
- Peter Silvera$18,392,128
- Nancy Lin$35,254,825
Others in their field
Top investigators on “Production”
- Eric S Lander · Whitehead Institute For Biomedical Res$568,626,051
- Bambra Strokes · Ppd Development Lp$526,656,217
- Richard A Gibbs · Baylor College Of Medicine$521,766,399
- Tracy L Nolen · Research Triangle Institute$451,761,218
- Sonia M Thomas · Research Triangle Institute$451,761,218
- David Heimbrook · Leidos Biomedical Research, Inc.$332,994,970
Research focus
ProductionDocumentationResearch Clinical TestingFlexibilityResearch StudyPreclinical TestingNational Institute Of Allergy And Infectious DiseaseInvestigator-Initiated ResearchInvestigational DrugsContractsAids PreventionAuthoritySafetyImmunogenicityModalityPamphletsProtocols DocumentationResearch PersonnelHiv VaccineMicrobicideGuidelinesInvestigational New Drug ApplicationPre-ClinicalPreclinical Development
Grant awards (19)
IGF::OT::IGF SMARTT BIOLOGICS PRODUCTION FACILITY (PF); BASE PERIOD; FY16; AMT $2,069,079; CAN 8470205$162,809
N01 · FY2023 · HL · contact PI
PRECLINICAL SERVICES FOR BIOPHARMACEUTICAL PRODUCT DEVELOPMENT$743
N01 · FY2023 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140$115,996
N01 · FY2022 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140$141,348
N01 · FY2020 · AI · contact PI
PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE$2,120,046
N01 · FY2019 · AI · contact PI
IGF::OT::IGF SMARTT BIOLOGICS PRODUCTION FACILITY (PF); BASE PERIOD; FY16; AMT $2,069,079; CAN 8470205$1,888,867
N01 · FY2017 · HL · contact PI
NIAID Preclinical Development Support - Development of clade C Vaccine$479,765
N01 · FY2017 · AI · contact PI
NIAID Preclinical Development Support - HIV-1 Envelope Protein Production$181,774
N01 · FY2017 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140$81,463
N01 · FY2017 · AI · contact PI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENVELOPE TRIMER PROTEINS$3,895,683
N01 · FY2016 · AI · contact PI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140$3,179,009
N01 · FY2016 · AI · contact PI
NIAID Preclinical Development Support$2,390,291
N01 · FY2016 · AI · contact PI
IGF::OT::IGF SMARTT BIOLOGICS PRODUCTION FACILITY (PF); BASE PERIOD; FY16; AMT $2,069,079; CAN 8470205$2,069,096
N01 · FY2016 · HL · contact PI
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE$1,880,590
N01 · FY2016 · AI · contact PI
NIAID Preclinical Development Support - HIV-1 Envelope Protein Production$245,514
N01 · FY2016 · AI · contact PI
NIAID Preclinical Development Support - Development of clade C Vaccine$67,221
N01 · FY2016 · AI · contact PI
PRECLINICAL SERVICES FOR BIOPHARMACEUTICAL PRODUCT DEVELOPMENT: TASK F$22,063
N01 · FY2016 · AI · contact PI
NIAID Preclinical Development Support - HIV-1 Envelope Protein Production$3,629,331
N01 · FY2015 · AI · contact PI
NIAID Preclinical Development Support - Development of clade C Vaccine$998,870
N01 · FY2015 · AI · contact PI